Vivebiotech participated in the conference “The Parks in the Press” that was held on November 29 in Madrid, an event that had as main objective to have a close contact with journalists from the Spanish press to tell them what a Technology Park is, as well as to give them to know which top-level scientific-technological companies are installed in the Spanish parks.

VIVEbiotech participated in the Bio-Europe conference that took place in Hamburg, Germany, on November 11, 12 and 13. Bio-Europe is an international partnering conference, and this year its 25th edition was celebrated.

The 27th annual congress of the ESGCT, the European Society of Gene and Cell Therapy, was held in Barcelona from October 22 to 25.

VIVEbiotech and VIRALGEN, specialized in the production of viral vectors for gene therapy, have organized the I Symposium on Gene Therapy Manufacturing, a meeting that will take place in San Sebastián on October 21.

VIVEbiotech has participated in two international conferences specialized in gene therapy in the months of September and October of this year.

VIVEbiotech has carried out a capital increase of 3.5 million euros to finance its strategic plan, which highlights the construction of three new cleanrooms and the incorporation of new equipment that will multiply its production capacity substantially.